Navigation Links
FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
Date:3/11/2008

Committee Recommends FDA Approve Novel Anesthesia Drug to Reverse Muscle

relaxation within Minutes

KENILWORTH, N.J., March 11 /PRNewswire-FirstCall/ -- Schering-Plough (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) Advisory Committee on Anesthetics and Life Support has recommended sugammadex for approval. After reviewing data on the safety and efficacy of the medication, the committee unanimously recommended approval of the company's application for marketing.

The FDA is not bound by the committee's recommendations; however, they usually are considered carefully before a final decision on approval is made.

Upon FDA approval, sugammadex will be the first and only selective relaxant binding agent (SRBA) and will give anesthesiologists the ability to rapidly and predictably reverse any depth of muscle relaxation induced by rocuronium and vecuronium within minutes. Sugammadex allows for flexible dosing of muscle relaxation agents enabling anesthesiologists to maintain optimal block through the end of the procedure.

"We are very pleased with the outcome of today's advisory committee meeting and appreciate the panel's careful consideration of the data on sugammadex," said Robert J. Spiegel, M.D., Chief Medical Officer and Senior Vice President, Schering-Plough Research Institute. "Sugammadex has the potential to transform the practice of anesthesia through improved management of muscle relaxation in the millions of surgeries where these agents are used. We will continue to work with FDA to bring sugammadex to the U.S. market as soon as possible so that anesthesiologists and their patients can benefit from this innovative product."

Earlier this year, Scherin
'/>"/>

SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
2. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
3. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
4. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
7. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
8. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
9. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
10. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
11. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Stoltenberg Consulting , a ... announced the celebration of its 20-year anniversary and ... since its inception in 1995. ... the healthcare technology industry continues, we strive to ... to facilitating clients, organizational goals, understanding that today,s ...
(Date:6/2/2015)... their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 As an industry-leading ...
(Date:6/2/2015)...  Ashion™ Advanced Individual Medicine™ (AIM), a ... industry, announced today the launch of its ... Medicine Platform. AIM develops and manages comprehensive ... healthcare systems, providing these centers with clinical ... operational support. AIM will use Syapse,s precision ...
Breaking Medicine Technology:Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 2Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 3
... Services Holdings Limited (the "Company" or "Concord Medical") (NYSE: ... of radiotherapy and diagnostic imaging centers in China, today ... of shareholders held in Beijing on November 26, 2011. ... "THAT Article 82(a) of the Articles of Association of ...
... -- Global Information, Inc. presents " Polycystic Ovarian ... to 2018 "  by GlobalData. (Photo:  ... a common chronic disorder of the endocrine system in ... years old) and is thought to be one of ...
Cached Medicine Technology:Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes 2Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes 3Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes 4Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes 5Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes 6GiiResearch.com: Polycystic Ovarian Syndrome (PCOS) Therapeutics - Market to Witness Static Growth Until 2018 2GiiResearch.com: Polycystic Ovarian Syndrome (PCOS) Therapeutics - Market to Witness Static Growth Until 2018 3
(Date:6/2/2015)... (PRWEB) June 02, 2015 Highly qualified dental ... a plan to drive prolific change in the dental tourism ... TDC Team Dental Clinic offers a full range of ... management structure for dental tourism. , Partnered with a ... is committed to advancing dentistry and has earned a reputation ...
(Date:6/2/2015)... UCLA Health and Exer have completed ... and expand urgent care services in Los Angeles County. ... University of California Board of Regents and the Exer ... Health to purchase a minority share of four existing ... Park and Northridge and creates opportunity to grow and ...
(Date:6/2/2015)... Gujarat, India (PRWEB) June 02, 2015 ... finalist in the 2015 Microsoft Worldwide Small and Midsized ... global field of top Microsoft partners for demonstrating excellence ... Microsoft technology. , “This comes as no surprise ... are recognized third year consecutively at worldwide level by ...
(Date:6/2/2015)... TX, USA (PRWEB) June 02, 2015 ... microsystems, is deploying its growth strategy to benefit from ... BioMEMS: “In Yole Développement’s May 2015 Status of the ... will grow sharply and reach $6.6B in 2020,” says ... Yole Développement . , The analyst adds that ...
(Date:6/2/2015)... MI (PRWEB) June 02, 2015 Erbelli’s ... new website to promote its handmade gourmet pizzas and ... even though the website is new, the recipes are ... since 1995. The main feature of the site is ... appetizing pictures and descriptions of all the items. You ...
Breaking Medicine News(10 mins):Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2
... 4 million men in the United States have low ... include erectile dysfunction, reduced muscle mass, reduced bone density, ... to increase testosterone levels for men with the condition. ... gel, or tablet. New research shows testosterone replacement therapy ...
... of osteoporosis. Such a break can lead to acute and ... to a recent study , it was found that the ... effective in reducing the risk for a vertebral fracture, according ... can reduce the risk of breaking a bone in the ...
... migraine headaches may be at risk for brain // lesions ... tissue has died. ,Researchers studied nearly 400 randomly ... into categories of having migraines with visual difficulties and having ... included in the study. Participants had a brain magnetic resonance ...
... shows only 7 percent of diabetics take the ... blood vessel problems. Researchers stressed continued negligence by ... retinopathy, neuropathy, nephropathy, coronary heart disease, stroke, and ... adults, ages 20 years or older, who had ...
... risk factors for melanoma skin cancer.// Previous research also shows ... detected early. ,New research shows patients who use photographs ... keep better track of new or changed moles. Researchers in ... atypical nevi, or pigmented moles that may change shape or ...
... age a person develops asthma may help explain their disease ... with asthma as children // have a different disease than ... patients suffered different symptoms and disease progression based on the ... that could not be controlled by steroids participated in the ...
Cached Medicine News:Health News:Onset Linked To Severity of Asthma 2
Standard 20x long working distance objectives for greater magnifications of your microtools....
... An economical laboratory tissue culture microscope, the ... expand their applications. Olympus has taken the ... CKX41. Fluorescence can be used with an ... can be carried out on the CKX41 ...
... Eclipse TE2000S is an advanced ... research. It's exclusive CFI60 optical ... high numerical aperatures and longer ... inverted microscope to take full ...
... new Eclipse TS-100 is an innovative ... high quality tool complements any research ... CFI60 optics offer brilliant, sharp ... superb optical performance with high resolution ...
Medicine Products: